Results 31 to 40 of about 32,781,578 (215)
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani +7 more
wiley +1 more source
Objective: Functional constipation affects up to one third of children. When standard treatments fail, the child may be referred to rectal biopsy on the suspicion of Hirschsprung’s disease (HD), but only 7–28% will have a confirmed HD.
Niels Bjørn +5 more
doaj +1 more source
Background The association of early changes in the immune infiltrate during neoadjuvant chemotherapy (NACT) with pathological complete response (pCR) in triple-negative breast cancer (TNBC) remains unexplored.Methods Multiplexed immunohistochemistry was ...
Eva-Maria Grischke +21 more
doaj +1 more source
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben +4 more
wiley +1 more source
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
We reported the main results of the Japanese Registry of Neuroendovascular Therapy (JR-NET) 4, a nationwide surveillance of therapy (NET) in Japan from January 2015 to December 2019.
Nobuyuki SAKAI +18 more
doaj +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
目的 基于中国急性缺血性卒中静脉替奈普酶治疗(intravenous TNK for acute ischemic stroke in China,INTACT-China)前瞻性、多中心登记研究的数据,探索替奈普酶静脉溶栓治疗急性缺血性卒中的结局预测因素。 方法 对INTACT-China研究中具有90 d结局且基线临床资料完整的患者进行事后分析。根据90 d mRS评分将患者分为结局良好(mRS评分0~1分)组和结局不良(mRS评分2~6分)组,进行组间比较及多因素logistic回归分析 ...
崔钰,王璐,陈会生CUI Yu, WANG Lu, CHEN Huisheng
doaj +1 more source
Cancer in Ireland 1994-2005: a summary [PDF]
National Cancer Registry, Ireland ...
National Cancer Registry Ireland (NCRI)
core
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source

